All lobbying filings

THE MCMANUS GROUP

Lobbying for ZIMMER BIOMET · A global leader in musculoskeletal healthcare.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 3006
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an am…
S 1776
Medicare Beneficiary Co-Pay Fairness Act
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 8413
SECURE Data Act

Lobbying activity 2

Medicare/Medicaid

Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)

Health Issues

Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.